Ubiquitin signaling in pancreatic ductal adenocarcinoma

被引:2
|
作者
Lv, Shengnan [1 ]
Zhang, Jian [1 ]
Peng, Xinyu [1 ]
Liu, Huan [1 ]
Liu, Yan [2 ]
Wei, Feng [1 ]
机构
[1] First Hosp Jilin Univ, Gen Surg Ctr, Dept Hepatobiliary & Pancreat Surg, Changchun, Jilin, Peoples R China
[2] Chinese Acad Agr Sci, Changchun Vet Res Inst, Key Lab Jilin Prov Zoonosis Prevent & Control, Changchun, Peoples R China
基金
中国国家自然科学基金;
关键词
pancreatic ductal adenocarcinoma; ubiquitination; ubiquitin-protein ligases; deubiquitinating enzymes; proteolysis-targeting chimeras; CANCER PROGRESSION; ACHIEVES SAFE; BETA-CATENIN; PROMOTES; GROWTH; PROTAC; CHEMORESISTANCE; EXPRESSION; PROTEINS; PROLIFERATION;
D O I
10.3389/fmolb.2023.1304639
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignant tumor of the digestive system, characterized by rapid progression and being prone to metastasis. Few effective treatment options are available for PDAC, and its 5-year survival rate is less than 9%. Many cell biological and signaling events are involved in the development of PDAC, among which protein post-translational modifications (PTMs), such as ubiquitination, play crucial roles. Catalyzed mostly by a three-enzyme cascade, ubiquitination induces changes in protein activity mainly by altering their stability in PDAC. Due to their role in substrate recognition, E3 ubiquitin ligases (E3s) dictate the outcome of the modification. Ubiquitination can be reversed by deubiquitylases (DUBs), which, in return, modified proteins to their native form. Dysregulation of E3s or DUBs that disrupt protein homeostasis is involved in PDAC. Moreover, the ubiquitination system has been exploited to develop therapeutic strategies, such as proteolysis-targeting chimeras (PROTACs). In this review, we summarize recent progress in our understanding of the role of ubiquitination in the development of PDAC and offer perspectives in the design of new therapies against this highly challenging disease.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] TGFβ signaling in pancreatic ductal adenocarcinoma
    Zhang, Hui
    Liu, Chengli
    Kong, Yalin
    Huang, Hui
    Wang, Cheng
    Zhang, Hongyi
    TUMOR BIOLOGY, 2015, 36 (03) : 1613 - 1618
  • [2] Targeting hedgehog signaling in pancreatic ductal adenocarcinoma
    Quatannens, Delphine
    Verhoeven, Yannick
    Van Dam, Peter
    Lardon, Filip
    Prenen, Hans
    Roeyen, Geert
    Peeters, Marc
    Smits, Evelien L. J.
    Van Audenaerde, Jonas
    PHARMACOLOGY & THERAPEUTICS, 2022, 236
  • [3] MicroRNA Signaling Pathway Network in Pancreatic Ductal Adenocarcinoma
    Sun, Longhao
    Chua, Corrine Ying Xuan
    Tian, Weijun
    Zhang, Zhixiang
    Chiao, Paul J.
    Zhang, Wei
    JOURNAL OF GENETICS AND GENOMICS, 2015, 42 (10) : 563 - 577
  • [4] Prognostic significance of WNT signaling in pancreatic ductal adenocarcinoma
    Nakamoto, Mitsuhiro
    Matsuyama, Atsuji
    Shiba, Eisuke
    Shibuya, Ryo
    Kasai, Takahiko
    Yamaguchi, Koji
    Hisaoka, Masanori
    VIRCHOWS ARCHIV, 2014, 465 (04) : 401 - 408
  • [5] Prognostic significance of WNT signaling in pancreatic ductal adenocarcinoma
    Mitsuhiro Nakamoto
    Atsuji Matsuyama
    Eisuke Shiba
    Ryo Shibuya
    Takahiko Kasai
    Koji Yamaguchi
    Masanori Hisaoka
    Virchows Archiv, 2014, 465 : 401 - 408
  • [6] MicroRNA Signaling Pathway Network in Pancreatic Ductal Adenocarcinoma
    Longhao Sun
    Corrine Ying Xuan Chua
    Weijun Tian
    Zhixiang Zhang
    Paul J.Chiao
    Wei Zhang
    Journal of Genetics and Genomics, 2015, 42 (10) : 563 - 577
  • [7] GPCR signaling in diabetes, pancreatic development and ductal adenocarcinoma
    Wilkie, Thomas Martin
    FASEB JOURNAL, 2011, 25
  • [8] NADK is activated by oncogenic signaling to sustain pancreatic ductal adenocarcinoma
    Schild, Tanya
    McReynolds, Melanie R.
    Shea, Christie
    Low, Vivien
    Schaffer, Bethany E.
    Asara, John M.
    Piskounova, Elena
    Dephoure, Noah
    Rabinowitz, Joshua D.
    Gomes, Ana P.
    Blenis, John
    CELL REPORTS, 2021, 35 (11):
  • [9] A novel hedgehog signaling inhibitor for targeting pancreatic ductal adenocarcinoma
    Khire, Atul
    Zhong, Yi
    Rajanala, Kalpana
    Iacobuzio-Donahue, Christine
    Resh, Marilyn D.
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Tuft cell chemosensory signaling during pancreatic ductal adenocarcinoma
    Hoffman, Megan T.
    Crawford, Howard
    CANCER RESEARCH, 2018, 78 (13)